Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing.
Naeem M, Majeed S, Hoque MZ, Ahmad I. · 2020
Read Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing. by Naeem M, Majeed S, Hoque MZ, Ahmad I. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7407193.txt.
Introduction
Naeem and co-authors review ways to curb off-target damage in CRISPR gene editing, in Cells. CRISPR-Cas9 is simpler, cheaper, and more efficient than older editors, but it sometimes cuts DNA at look-alike sites. Those stray cuts are the system's crucial shortcoming for medicine.
The review sorts the fixes. Some detect stray cuts better. Others use gentler editors that swap single letters without full cuts, or prime editing, or tamed Cas9 forms. Paired nickase enzymes cut only when both halves agree. Delivery as short-lived protein complexes limits exposure time. Shortened guide RNAs also sharpen aim. Each approach trades some efficiency for safety. Readers get a current catalogue for judging how cleanly a given editing job can be done.
Catalog record
| CREATOR | Naeem M, Majeed S, Hoque MZ, Ahmad I. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 83 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing By Muhammad Naeem, Saman Majeed, Mubasher Zahir Hoque, Irshad Ahmad Published in: Cells DOI: 10.3390/cells9071608 ABSTRACT Abstract Gene editing that makes target gene modification in the genome by deletion or addition has revolutionized the era of biomedicine. Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 emerged as a substantial tool due to its simplicity in use, less cost and extraordinary efficiency than the conventional gene-editing tools, including zinc finger nucleases (ZFNs) and Transcription activator-like effector nucleases (TALENs). However, potential off-target activities are crucial shortcomings in the CRISPR system. Numerous types of approaches have been developed to reduce off-target effects. Here, we review several latest approaches to reduce the off-target effects, including biased or unbiased off-target detection, cytosine or adenine base editors, prime editing, dCas9, Cas9 paired nickase, ribonucleoprotein (RNP) delivery and truncated gRNAs. This review article provides extensive information to cautiously interpret off-target effects to assist the basic and clinical applications in biomedicine. Keywords: CRISPR/Cas9, gene targeting, targeting specificity, homology dependent repair, base editors, non-homologous end joining repair pathway 1. INTRODUCTION Genome editing, a powerful toolset involving deliberate changes in the DNA sequence, is leading to a new era of molecular medicine against cancer, genetic disorders and beyond [1]. Editing methods currently available include zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR). CRISPR was identified as the antiviral immune system of archaea and bacteria and later adopted as a competent tool for gene editing [2]. CRISPR/Cas9 is extensively used for gene editing than ZFNs and TALENs due to cost-effective, highly efficient, easy to use and highly effective [3]. The components of CRISPR/Cas9 are guide RNA (gRNA) and Cas9 nuclease. gRNA is a custom-designed short nucleotide base RNA that recruits Cas9 to cleave and edit specific loci in the genome. The CRISPR/Cas9 induce specific double-strand breaks (DSBs) inside double-strand DNA that trigger DNA repair pathways, such as non-homologous end joining (NHEJ) to introduce frameshift mutation for gene knock out (KO) or homologous direct repair pathway (HDR) for gene substitution or gene knock-in (KI) through supplied template DNA [4]. CRISPR/Cas9 genome editing has exploited in bacteria [5], plants [6] and mammals [7,8]. CRISPR/Cas9 has therapeutic potential in future clinical genetics, which leads to the approval of clinical trials in the USA to reduce genetic diseases [9]. Clinical trial data and comparative characteristics between CRISPR/Cas, ZFNs and TALENs on the nuclease platform depicted in Table 1. [Table: Comparison between ZFNs, TALENs and CRISPR/Cas on the nuclease platform and clinical trial data [16].] Several studies have revealed that Cas9 binds to unintended genomic sites for cleavage, termed as off-target effects [10]. The target efficiency of CRISPR/Cas9 determined through 20 nucleotide sequences of gRNA and PAM sites adjacent to target loci. More than three mismatches between target sequences and 20 nucleotides of gRNA can result in off-target effects [11]. It has demonstrated that 4 mismatches in PAM-distal end induce off-target effects [12]. Researchers have proposed two types of off-target effects, the first types of off-target effects likely to occur due to the sequence homology of the target loci and the next types of off-target sites occur in the genome other than the target site. Off-target effects cause a severe type of problem in the organism at the genomic level, large deletions and genomic rearrangements, which rarely could occur as a consequence of dsDNA breaks [13]. Off-target effects could lead to lethal genetic mutations that cause loss of gene function, ultimately cancer cells in animals and undesirable phenotype (disease sensitivity) in plants [14] (Figure 1). [Figure: Effects of off-target mutation on animal and plant phenotype. Off-target causes genetic mutations. In clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system gRNA sometimes binds other than target loci, off-target site. It may activate the oncogenes that initiate tumor cell formation in the animal body or may change gene function that leads to undesirable phenotypic expression (sensitive to diseases) in plants. The figure has been created with BioRender.com.] The CRISPR–Cas9 system has the advantage that it can be transferred in distinct forms viz; Cas9–gRNA ribonucleoprotein (RNP), in plasmid/viral vectors and Cas9, mRNA with a distinct gRNA. In vivo delivery of CRISPR/Cas9 through viral vectors linked with some challenges for clinical applications, including; prolonged expression of CRISPR–Cas9, relatively high cost of production, immunogenicity and unintended mutagenesis in addition to editing in the off-target tissues [15]. Preclinical development for any genome editing treatment demands mitigation and thorough study of off-target risks before direct testing in humans. The selected loci is ideal if it has a relatively low degree of homology with the remaining genome sequence. This article reviews and highlights the CRISPR/Cas9 linked to the latest developed strategies to decrease the off-target effects or limitations in CRISPR mediated genome editing. 2. MITIGATION OF OFF-TARGET EFFECTS: BIASED AND UNBIASED OFF-TARGET DETECTION METHODS Native CRISPR/Cas9 system is an adaptive immune system in bacteria that protect the bacterial genome integrity from invading viruses [4]. The Cas9 specificity is very high in bacteria due to the small genome size than the eukaryotic genome, which is 1,000-fold larger than bacteria. Cas9 in bacteria has evolved without selection pressure; hence, there are high chances of off-target effects in the mammalian genome than bacteria [18]. Off-target cleavage sites have been detected in gene-editing techniques, CRISPR/Cas9, ZFNs and TALEN [19] but also in gene knockdown tools such as RNA interference (RNAi) and antisense [20,21]. Off-target effects in gene editing cause severe risks in clinical therapies. Researchers have discovered in vivo/vitro biochemical assays and algorithm-based computational approaches to detect and quantify the off-target effects to increase gene editing efficiency. Off-target detection methods categorized into two groups, biased and unbiased detection. 2.1. Biased Careful designing of gRNA is crucial for the precise CRISPR/Cas9 targeting. For successful CRISPR/Cas9 research, off-target effects can be predicted through in silico tools [22]. The author identified that CRISPR/Cas9 could generate off-target sites under certain conditions; further, many scientist start to produce abundant data on off-target sites by using different CRISPR systems with different strategies [23,24,25]. Data generated is used to develop algorithmically based in silico predictive models to detect and quantify off-target effects. In silico prediction can minimize off-target effects through algorithmically designed software. Algorithmic based models were categorized into two groups (1) alignment-based models, Conventional algorithm based in which gRNA aligned to the reference genome and off-target effects returned on the base of sequence homology; (2) Scoring based models, advanced algorithmically designed, the most appropriate gRNA picked for the experiment from the given scores and ranking based on identified off-targets sites [26,27]. Biased methods illustrated in Table 2. [Table: Biased tools to detect and evaluate the guide RNA (gRNA) efficiency.] 2.1.1. Alignment Based Models In this, the off-target sites predicted after aligning the gRNA sequences with reference genome sequences on a homology basis. It includes Bowtie, BWN, CasOT, Cas-OFFinder, FlashFry and CrisFlash. Bowtie and BWN are ideal tools to detect off-target effects based on simple alignment, which can detect off-target up to one mismatch [28,29]. The CRISPR/Cas9 target online predictor (CCTop, http://crispr.cos.uni-heidelberg.de), utilizes Bowtie to detect off-target activities that identify the PAM site to match and mismatch with protospacer sequence and then search by different parameters.